Morphine use in acute coronary syndrome may increase mortality

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1488, 2005-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Association of Dyslipidemia and Concomitant Risk Factors with In-Hospital Mortality in Acute Coronary Syndrome in Switzerland

By  

Heart Drug, Vol. 5, Iss. 3, 2005-06 ,pp. : 131-139

Karger

Access to resources Recommend Favorite

Paroxetine/tamoxifen interaction may increase mortality

By  

Reactions Weekly, Vol. 1, Iss. 1288, 2010-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Women and the management of acute coronary syndrome

By Ostadal Bohuslav  

Canadian Journal of Physiology and Pharmacology, Vol. 90, Iss. 9, 2012-08 ,pp. : 1151-1159

NRC Research Press

Access to resources Recommend Favorite

Fondaparinux: A Pharmacoeconomic Review of its Use in the Management of Non-ST-Segment Elevation Acute Coronary Syndrome

By McKeage Kate   Lyseng-Williamson Katherine A.  

PharmacoEconomics, Vol. 28, Iss. 8, 2010-08 ,pp. : 687-698

Adis International

Access to resources Recommend Favorite

Use of the recommended drug combination for secondary prevention after a first occurrence of acute coronary syndrome in France

By Bezin J.   Pariente A.   Lassalle R.   Dureau-Pournin C.   Abouelfath A.   Robinson P.   Moore N.   Droz-Perroteau C.   Fourrier-Reglat A.  

European Journal of Clinical Pharmacology, Vol. 70, Iss. 4, 2014-04 ,pp. : 429-436

Springer Publishing Company

Access to resources Recommend Favorite